Danielle Duszczyszyn

Danielle Duszczyszyn, Ph.D., focuses her practice on patent litigation before U.S. district courts, patent prosecution, and client counseling in the areas of biotechnology, pharmaceuticals, and chemical arts. She works on litigation matters in a variety of technologies in the pharmaceutical, cosmetic, medical device and biotechnology fields, and has experience in cases arising from the filing of Abbreviated New Drug Applications (ANDA).

Danielle has been involved in all stages of district court litigation, from complaint to trial and post-trial. Her litigation experience includes analyzing patent portfolios for assertion; formulating claim construction, infringement, and validity positions; drafting discovery requests and responses; taking and defending fact and expert depositions; preparing witnesses for deposition, Markman hearings, and trial; examining expert witnesses at trial; and drafting summary judgment motions and briefs, Markman briefs, pre- and post-trial motions and briefs, findings of fact, and conclusions of law.

In addition to her litigation practice, Danielle advises clients on a variety of patent matters, including patent procurement, and pre- and post-litigation strategies.

Prior to her legal career, Danielle worked in the pharmaceutical and cosmetic industries. She worked as a research assistant at small biotechnology companies and at the W.M. Keck Center for Transgene Research at the University of Notre Dame. She also gained experience in clinical trial research by working on Phase II, III, and IV clinical trials at two major pharmaceutical companies. Danielle received her Ph.D. from McGill University, where she studied perturbed naïve T cell homeostasis and thymic abnormalities in patients with relapsing-remitting multiple sclerosis.

Danielle is a current member of the firm’s management committee. She has been recognized by Managing Intellectual Property (MIP) as a notable practitioner.